The weekly litigation news digest is live. Subscribe now

Hiv Treatment Formulation Of Atazanavir And Cobicistat

Patent No. EP3054926 (titled "Hiv Treatment Formulation Of Atazanavir And Cobicistat") was filed by Bristol Myers Squibb Ireland on Oct 6, 2014. The application was issued on Jul 25, 2018.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
TEVA PHARMACEUTICALS	Apr 24, 2019	BEST

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Jul 10, 2020
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Jul 10, 2020
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Jul 7, 2020
Termination of the opposition proceedings with maintenance of patent
Apr 9, 2020
(Electronic) Receipt
Apr 9, 2020
Advice of delivery
Apr 9, 2020
Letter accompanying subsequently filed items
Mar 26, 2020
Acknowledgement of a document
Mar 26, 2020
Decision to discontinue the opposition proceedings
Mar 26, 2020
Notification concerning the date of oral proceedings
Mar 24, 2020
Brief communication - Opposition proceedings
Mar 23, 2020
Brief communication - Opposition proceedings
Mar 23, 2020
Brief communication - Opposition proceedings
Mar 17, 2020
(Electronic) Receipt
Mar 17, 2020
Letter accompanying subsequently filed items
Mar 17, 2020
Notification concerning the date of oral proceedings
Mar 17, 2020
Notification concerning the date of oral proceedings
Mar 17, 2020
Withdrawal of an opposition
Mar 13, 2020
Brief communication - Opposition proceedings
Mar 9, 2020
(Electronic) Receipt
Mar 9, 2020
Letter accompanying subsequently filed items
Mar 9, 2020
Withdrawal of a request for oral proceedings
Jan 8, 2020
(Electronic) Receipt
Jan 8, 2020
Advice of delivery
Jan 8, 2020
Letter accompanying subsequently filed items
Jan 7, 2020
Advice of delivery
Jan 3, 2020
Acknowledgement of a document
Jan 3, 2020
Acknowledgement of a document
Jan 3, 2020
Annex to the communication - opposition
Jan 3, 2020
Information concerning oral proceedings
Jan 3, 2020
Summons to attend oral proceedings
Jan 3, 2020
Summons to attend oral proceedings
Nov 13, 2019
Brief communication - Opposition proceedings
Nov 7, 2019
(Electronic) Receipt
Nov 7, 2019
Citation in opposition procedure - 012
Nov 7, 2019
Citation in opposition procedure - 013
Nov 7, 2019
Citation in opposition procedure - 014
Nov 7, 2019
Citation in opposition procedure - 015
Nov 7, 2019
Citation in opposition procedure - 016
Nov 7, 2019
Consolidated list of cited opposition documents
Nov 7, 2019
Letter accompanying subsequently filed items
Nov 7, 2019
Letter regarding the opposition procedure (no time limit)
Sep 24, 2019
Brief communication - Opposition proceedings
Sep 24, 2019
Brief communication - Opposition proceedings
Sep 20, 2019
Communication of the registration of a transfer or change of name and/or address
Sep 18, 2019
(Electronic) Receipt
Sep 18, 2019
Amended claims with annotations
Sep 18, 2019
Amended claims with annotations
Sep 18, 2019
Amended claims with annotations
Sep 18, 2019
Citation in opposition procedure - 006
Sep 18, 2019
Citation in opposition procedure - 007
Sep 18, 2019
Citation in opposition procedure - 008
Sep 18, 2019
Citation in opposition procedure - 009
Sep 18, 2019
Citation in opposition procedure - 010
Sep 18, 2019
Citation in opposition procedure - 011
Sep 18, 2019
Claims
Sep 18, 2019
Claims
Sep 18, 2019
Claims
Sep 18, 2019
Letter accompanying subsequently filed items
Sep 18, 2019
Reply of the patent proprietor to the notice(s) of opposition
Sep 18, 2019
Reply of the patent proprietor to the notice(s) of opposition
Sep 12, 2019
(Electronic) Receipt
Sep 12, 2019
Annexes in respect of a client data request
Sep 12, 2019
Letter accompanying subsequently filed items
Sep 12, 2019
Submission concerning change of proprietor's name
May 21, 2019
Brief communication - Opposition proceedings
May 21, 2019
Communication confirming withdrawal from representation
May 21, 2019
Communication of amended entries concerning the representative
May 16, 2019
(Electronic) Receipt
May 16, 2019
(Electronic) Receipt
May 16, 2019
Letter accompanying subsequently filed items
May 16, 2019
Letter accompanying subsequently filed items
May 16, 2019
Submission concerning change of proprietor's representative
May 16, 2019
Submission concerning change of proprietor's representative
May 8, 2019
Communication of a notice of opposition and request to file observations
May 8, 2019
Notice of further oppositions to opponent(s)
Apr 29, 2019
Communication of a notice of opposition - first information to patent proprietor
Apr 24, 2019
(Electronic) Receipt
Apr 24, 2019
Citation in opposition procedure - 001
Apr 24, 2019
Citation in opposition procedure - 002
Apr 24, 2019
Citation in opposition procedure - 003
Apr 24, 2019
Citation in opposition procedure - 004
Apr 24, 2019
Citation in opposition procedure - 005
Apr 24, 2019
Notice of opposition
Apr 24, 2019
Notice of opposition
Aug 6, 2018
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jun 28, 2018
Decision to grant a European patent
Jun 14, 2018
(Electronic) Receipt
Jun 14, 2018
Filing of the translations of the claims
Jun 14, 2018
French translation of claims
Jun 14, 2018
German translation of the claims
Jun 14, 2018
Letter accompanying subsequently filed items
Feb 28, 2018
Bibliographic data of the European patent application
Feb 28, 2018
Communication about intention to grant a European patent
Feb 28, 2018
Intention to grant (signatures)
Feb 28, 2018
Text intended for grant (clean copy)
Feb 28, 2018
Text intended for grant (version for approval)
Dec 5, 2017
(Electronic) Receipt
Dec 5, 2017
Amended claims with annotations
Dec 5, 2017
Amended description with annotations
Dec 5, 2017
Claims
Dec 5, 2017
Description
Dec 5, 2017
Letter accompanying subsequently filed items
Dec 5, 2017
Reply to communication from the Examining Division
Nov 14, 2017
Annex to the communication
Nov 14, 2017
Communication from the Examining Division
Aug 3, 2017
(Electronic) Receipt
Aug 3, 2017
Amended claims with annotations
Aug 3, 2017
Claims
Aug 3, 2017
Letter accompanying subsequently filed items
Aug 3, 2017
Reply to communication from the Examining Division
Mar 24, 2017
Annex to the communication
Mar 24, 2017
Communication from the Examining Division
Mar 14, 2017
Examination started
Nov 3, 2016
(Electronic) Receipt
Nov 3, 2016
Amended claims filed after receipt of (European) search report
Nov 3, 2016
Amended claims with annotations
Nov 3, 2016
Amendments received before examination
Nov 3, 2016
Letter accompanying subsequently filed items
Jul 20, 2016
Notification on forthcoming publication of bibliographic data
May 13, 2016
Communication regarding comments on written opinion/amendment of application/payment of claims fee
May 11, 2016
Communication to designated inventor
May 11, 2016
Communication to designated inventor
May 11, 2016
Communication to designated inventor
May 11, 2016
Communication to designated inventor
May 11, 2016
Communication to designated inventor
Apr 28, 2016
Copy of the international preliminary report on patentability
Mar 23, 2016
(Electronic) Receipt
Mar 23, 2016
Amended claims filed after receipt of (European) search report
Mar 23, 2016
Request for entry into the European phase
Mar 10, 2016
Notification of the recording of a change
Mar 10, 2016
Notification of the recording of a change
Feb 19, 2016
Information on entry into European phase
May 6, 2015
Priority document (electronically transmitted)
Apr 16, 2015
Copy of the international search report
Apr 16, 2015
Published international application - A1
Dec 2, 2014
Written opinion of the ISA, boxes No. I to VIII
Dec 2, 2014
Written opinion of the ISA, cover sheet
Dec 2, 2014
Written opinion of the ISA, supplemental box
Oct 17, 2014
Abstract
Oct 17, 2014
Annex
Oct 17, 2014
Claims
Oct 17, 2014
Description
Oct 17, 2014
Drawings

EP3054926

BRISTOL MYERS SQUIBB IRELAND

Application Number: EP14786421A
Filing Date: Oct 6, 2014
Status: Granted And Under Opposition; Jun 22, 2018
Publication Date: Jul 25, 2018
External Links: Slate, EP3054926B1, Google Patents

IP Verse

Hiv Treatment Formulation Of Atazanavir And Cobicistat

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3054926